Rich represents high growth companies, investment banks and institutional investors in equity and debt offerings, with a focus on the technology and life sciences sectors. Rich also regularly counsels public companies on SEC compliance and reporting matters, as well as private companies on a wide variety of corporate and securities matters.

Download full bio 

Experience

  • Warby Parker – Direct Listing 

  • SOPHiA Genetics – $234 Million IPO 

  • GH Research – $184 Million IPO 

  • Verve Therapeutics – $307 Million IPO 

  • Talaris Therapeutics – $150 Million IPO 

  • View all

Education

  • Boston College Law School
    JD, cum laude, 2009

  • Dartmouth College
    AB, cum laude, 2005


Admissions & Credentials

Massachusetts

Rankings & Accolades

    Legal 500: Next Generation Partner – Capital Markets: Equity Offerings (2021)

    Massachusetts Super Lawyers: Rising Star – Securities & Corporate Finance (2013 – 2020)

    Chambers USA: Capital Markets – Massachusetts